Nanjing Pharmaceutical (600713.SH) issued 16.059 million restricted stocks for the first time to 173 incentive recipients.
Nanjing Pharmaceutical (600713.SH) released an announcement that the company has approved the "Restrictive Measures for the Company in 2025..."
Nanjing Pharmaceutical (600713.SH) announced that the company has approved the proposal "Regarding the Initial Grant of Restricted Stock to the Participants of the Company's 2025 Restricted Stock Incentive Plan." Due to the conditions for granting set out in the 2025 Restricted Stock Incentive Plan being achieved, the company has agreed to grant 16.059 million shares of restricted stock to 173 incentive recipients at a price of 2.46 yuan per share on May 9, 2025.
Related Articles
INTENDED TO DISTRIBUTE FINAL DIVIDEND OF RMB 0.2995 PER SHARE
US Stock Market Move | Q2 guidance exceeds expectations, Pinterest (PINS.US) surges over 7%
APAC Resources (01104) acquiring subsidiary NOVAGOLD shares
INTENDED TO DISTRIBUTE FINAL DIVIDEND OF RMB 0.2995 PER SHARE
US Stock Market Move | Q2 guidance exceeds expectations, Pinterest (PINS.US) surges over 7%
APAC Resources (01104) acquiring subsidiary NOVAGOLD shares
RECOMMEND
General Administration of Customs: China's goods trade imports and exports increased by 2.4% year-on-year in the first 4 months.
09/05/2025
Key details are yet to be finalized. The market's response to the US-UK trade agreement has been lukewarm.
09/05/2025
Risk assets rebounded to boost the market, Bitcoin surged back above $100,000.
09/05/2025
